Celavie Biosciences CEO Sandy Solomon sat down with Proactive’s Christine Corrado at the BIO CEO & Investor Conference in New York. The California-based company is developing regenerative stem cell therapies to treat Parkinson’s disease and other central nervous system disorders.
Director Interviews
Christine Corrado
17:04 Tue 11 Feb 2020
viewCelavie Biosciences
Celavie Biosciences advancing its five year exploratory study in Parkinson's Disease
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
FOR OUR FULL DISCLAIMER CLICK HEREMost read
Health
Moderna hit by criticism over lack of data on coronavirus vaccine candidate...
5 days, 17 hours ago
